| http://dbpedia.org/ontology/abstract
|
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
|
| http://dbpedia.org/ontology/foundingYear
|
2008
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/John_Bell_%28physician%29 +
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Cancer +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Logo_of_Immunocore.gif?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.immunocore.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
39913823
|
| http://dbpedia.org/ontology/wikiPageLength
|
8129
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1081134094
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/File:Wiki_ImmTAC_mechanism_of_action_diseased_cell.png +
, http://dbpedia.org/resource/Immune_system +
, http://dbpedia.org/resource/Biopharmaceutical +
, http://dbpedia.org/resource/Immunostimulant +
, http://dbpedia.org/resource/John_Bell_%28physician%29 +
, http://dbpedia.org/resource/Human_immunodeficiency_virus_%28HIV%29 +
, http://dbpedia.org/resource/Fidelity_Management_&_Research +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2008 +
, http://dbpedia.org/resource/England +
, http://dbpedia.org/resource/Antigen +
, http://dbpedia.org/resource/T_cell +
, http://dbpedia.org/resource/Chairman_of_the_board +
, http://dbpedia.org/resource/Oxford +
, http://dbpedia.org/resource/Antigen_presentation +
, http://dbpedia.org/resource/Cancer +
, http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Tebentafusp +
, http://dbpedia.org/resource/Antibody-drug_conjugate +
, http://dbpedia.org/resource/US_FDA +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2008 +
, http://dbpedia.org/resource/Cell_%28biology%29 +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Uveal_melanoma +
, http://dbpedia.org/resource/Oxfordshire +
, http://dbpedia.org/resource/Category:Immunomodulating_drugs +
, http://dbpedia.org/resource/Category:2008_establishments_in_the_United_Kingdom +
, http://dbpedia.org/resource/T-cell_receptor +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_Kingdom +
|
| http://dbpedia.org/property/founded
|
in Oxford, England
|
| http://dbpedia.org/property/founders
|
Dr. Bent Jakobsen and James Noble
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Bahija Jallal, PhD, CEO; Sir John Bell, Chairman; Brian Di Donato, CFO and Head of Strategy; David Berman, MD, PhD, Head of R&D
|
| http://dbpedia.org/property/logo
|
File:Logo_of_Immunocore.gif
|
| http://dbpedia.org/property/logoSize
|
250
|
| http://dbpedia.org/property/name
|
Immunocore
|
| http://dbpedia.org/property/products
|
Cancer drugs/treatments using T-Cell receptor technology
|
| http://dbpedia.org/property/tradedAs
|
NASDAQ:IMCR
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/website
|
http://www.immunocore.com/ +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Start_date +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:EngvarB +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2008 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_Kingdom +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2008 +
, http://dbpedia.org/resource/Category:Immunomodulating_drugs +
, http://dbpedia.org/resource/Category:2008_establishments_in_the_United_Kingdom +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.450850.c +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Immunocore?oldid=1081134094&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Wiki_ImmTAC_mechanism_of_action_diseased_cell.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/Logo_of_Immunocore.gif +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.immunocore.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Immunocore +
|
| http://xmlns.com/foaf/0.1/name
|
Immunocore
|
| owl:sameAs |
http://yago-knowledge.org/resource/Immunocore +
, http://www.wikidata.org/entity/Q16985758 +
, https://global.dbpedia.org/id/fosN +
, http://dbpedia.org/resource/Immunocore +
, http://yago-knowledge.org/resource/ImmTAC +
, http://rdf.freebase.com/ns/m.0w7mmd0 +
|
| rdf:type |
http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Organisation +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedKingdom +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/Institution108053576 +
|
| rdfs:comment |
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
|
| rdfs:label |
Immunocore
|
